ATRACURIUM BESYLATE- atracurium besylate injection, solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

atracurium besylate- atracurium besylate injection, solution

mylan institutional llc - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection, usp is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it.

CISATRACURIUM BESYLATE injection Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cisatracurium besylate injection

sandoz inc - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium besylate injection is indicated: limitations of use cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium besylate injection have been reported [see warnings and precautions (5.4)] . the use of 10 ml cisatracurium besylate injection multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-weight infants because the formulation contains benzyl alcohol [see warnings and precautions (5.2) and use in specific populations (8.4)] . risk summary there are no adequate and well-controlled studies of cisatracurium besylate in pregnant women. animal studies conducted in rats administered cisatracurium besylate during organogenesis found no evidence of fetal harm at 0.8 times (ventilated rats) the exposure from a

CISATRACURIUM BESYLATE injection Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

cisatracurium besylate injection

somerset therapeutics, llc - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium besylate injection, usp is indicated: - as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age - to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu - to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection, usp is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. - cisatracurium besylate injection is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium besylate injection have been reported [see warnings and precautions (5.4)] . - the use of 10 ml cisatracurium besylate injection multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth-w

ATRACURIUM BESYLATE injection, solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

atracurium besylate injection, solution

auromedics pharma llc - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection, usp is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple-dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.

Cisatracurium Accord Healthcare 2 mg/ml inj./inf. sol. i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium accord healthcare 2 mg/ml inj./inf. sol. i.v. vial

accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium

Cisatracurium Accord Healthcare 2 mg/ml inj./inf. sol. i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium accord healthcare 2 mg/ml inj./inf. sol. i.v. vial

accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium

Cisatracurium Accord Healthcare 5 mg/ml inj./inf. sol. i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium accord healthcare 5 mg/ml inj./inf. sol. i.v. vial

accord healthcare b.v. - cisatracurium besilate 6,7 mg/ml - eq. cisatracurium 5 mg/ml - solution for injection/infusion - 5 mg/ml - cisatracurium besilate 6.7 mg/ml - cisatracurium

Cisatracurium Accord Healthcare 2 mg/ml inj./inf. sol. i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium accord healthcare 2 mg/ml inj./inf. sol. i.v. vial

accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium

Cisatracurium Accord Healthcare 2 mg/ml inj./inf. sol. i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium accord healthcare 2 mg/ml inj./inf. sol. i.v. vial

accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium

Cisatracurium Fresenius Kabi 2 mg/ml inj./inf. sol. i.v. amp. Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium fresenius kabi 2 mg/ml inj./inf. sol. i.v. amp.

fresenius kabi sa-nv - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium